As a first-line treatment for diabetes, the insulin-sensitizing biguanide, metformin, regulates
glucose levels and positively affects cardiovascular function in patients with diabetes and …

Aims/hypothesis To provide a systematic overview of the current body of evidence on high-
risk phenotypes of diabetes associated with COVID-19 severity and death. Methods This is …

Background Diabetes is an independent predictor of poor outcomes in patients with COVID-
19. We compared the effects of the preadmission use of antidiabetic medications on the in …

BackgroundPeople with neurodegenerative disease and mild cognitive impairment (MCI)
may have an elevated risk of acquiring severe acute respiratory syndrome coronavirus 2 …

Background Diabetes, a chronic disease worldwide, may be associated with a poorer
prognosis in patients with coronavirus disease 2019 (COVID-19). While some …

SARS-CoV-2 infection has been a major threat to human health and a huge challenge to
Medicine. In only two years, COVID-19 affected> 350 million people, causing> 5.6 million …

Aims We examined diabetes status (no diabetes; type 1 diabetes [T1D]; type 2 diabetes
[T2D]) and other demographic and clinical factors as correlates of coronavirus disease 2019 …

Background. Type 2 diabetes (T2D) as a worldwide chronic disease combined with the
COVID‐19 pandemic prompts the need for improving the management of hospitalized …

(1) Background: To assess changes in the prevalence of dementia among patients
hospitalized with type 2 diabetes (T2DM), to analyze the effects of dementia on in-hospital …

Introduction Diabetes is one of the comorbidities associated with poor prognosis in
hospitalized COVID-19 patients. In this nationwide retrospective study, we evaluated the risk …